{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T01:59:40Z","timestamp":1775959180373,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T00:00:00Z","timestamp":1469145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics &amp; Neonatology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.pedneo.2016.04.003","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T07:28:55Z","timestamp":1469604535000},"page":"541-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immunization status in childhood cancer survivors: A hidden risk which could be prevented"],"prefix":"10.1016","volume":"58","author":[{"given":"Najwa Yahya","family":"Fayea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf Elsayed","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaimaa Mohamed","family":"Kandil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2016.04.003_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0308-2261(21)00027-8","article-title":"Viral infections and haematological malignancies","volume":"5","author":"Feldman","year":"1976","journal-title":"Clin Haematol"},{"key":"10.1016\/j.pedneo.2016.04.003_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10428199309147369","article-title":"Active immunization of children with leukemia and other malignancies","volume":"9","author":"Ridgway","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pedneo.2016.04.003_bib3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/1097-0142(19920315)69:6<1481::AID-CNCR2820690628>3.0.CO;2-L","article-title":"Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia","volume":"69","author":"Alanko","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.pedneo.2016.04.003_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/08880019409141671","article-title":"Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia","volume":"11","author":"Alanko","year":"1994","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2016.04.003_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/mpo.2950240607","article-title":"Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors","volume":"24","author":"Alanko","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.pedneo.2016.04.003_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pbc.22256","article-title":"Survivors of childhood cancer: an Australian audit of vaccination status after treatment","volume":"54","author":"Crawford","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pedneo.2016.04.003_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/CDLI.3.1.84-88.1996","article-title":"Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay","volume":"3","author":"Madore","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.pedneo.2016.04.003_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/pbc.23320","article-title":"A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment","volume":"59","author":"Kazak","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pedneo.2016.04.003_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1086\/511636","article-title":"Revaccination of children after completion of standard chemotherapy for acute leukemia","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pedneo.2016.04.003_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.leu.2400970","article-title":"Profound abnormality of the B\/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia","volume":"12","author":"Caver","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.pedneo.2016.04.003_bib11","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1542\/peds.109.6.e91","article-title":"Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens","volume":"109","author":"Nilsson","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2016.04.003_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/cncr.20384","article-title":"Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy","volume":"101","author":"Zignol","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.pedneo.2016.04.003_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/00365540310016600","article-title":"Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancer","volume":"35","author":"Reinhardt","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.pedneo.2016.04.003_bib14","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/S0264-410X(00)00092-X","article-title":"Humoral immunity against diphtheria, tetanus, and poliomyelitis after antineoplastic therapy in children and adolescents\u2014A retrospective analysis","volume":"18","author":"von der Hardt","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.pedneo.2016.04.003_bib15","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/sj.leu.2404326","article-title":"Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: A systematic review","volume":"20","author":"van Tilburg","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.pedneo.2016.04.003_bib16","first-page":"887","article-title":"Immunization response varies with intensity of acute lymphoblastic leukemia therapy","volume":"145","author":"Ridgway","year":"1991","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.pedneo.2016.04.003_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00043426-200411000-00008","article-title":"Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus and Haemophilus influenzae type b","volume":"26","author":"Ek","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2016.04.003_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0609.2004.00340.x","article-title":"Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy","volume":"74","author":"Fioredda","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pedneo.2016.04.003_bib19","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1016\/j.vaccine.2014.04.042","article-title":"Differential loss of humoral immunity against measles, mumps, rubella, and varicella-zoster virus in children treated for cancer","volume":"32","author":"Bochennek","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.pedneo.2016.04.003_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00043426-199709000-00001","article-title":"Therapy-induced alterations in host defense in children receiving therapy for cancer","volume":"19","author":"Lehrnbecher","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2016.04.003_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1470-2045(08)70071-8","article-title":"Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies","volume":"9","author":"Lehrnbecher","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pedneo.2016.04.003_bib22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1086\/651950","article-title":"Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer","volume":"201","author":"Wiser","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pedneo.2016.04.003_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1651-2227.1995.tb13605.x","article-title":"Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow-up","volume":"84","author":"Abrahamsson","year":"1995","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.pedneo.2016.04.003_bib24","first-page":"1","article-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence","volume":"42","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.pedneo.2016.04.003_bib25","series-title":"Immunisation of the immunocompromised child: best practice statement","author":"Royal College of Paediatrics and Child Health (RCPCH)","year":"2002"}],"container-title":["Pediatrics &amp; Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957216300821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957216300821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T22:28:28Z","timestamp":1656887308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957216300821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1875957216300821"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2016.04.003","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization status in childhood cancer survivors: A hidden risk which could be prevented","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2016.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}